Raymond James Financial Inc. Takes Position in Editas Medicine, Inc. (NASDAQ:EDIT)
Raymond James Financial Inc. purchased a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 238,967 shares of the company’s stock, valued at approximately $303,000. A number of other institutional […]
Raymond James Financial Inc. purchased a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 238,967 shares of the company’s stock, valued at approximately $303,000. A number of other institutional […]
